A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Clinical trial NCT06547528 · RECRUITING
Trial details
- NCT number
- NCT06547528
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2029-01-31
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.